In Vitro and IN Vivo Studies of the Human IL-4 Receptor - David Seldin

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Heart, Lung, and Blood Institute (NHLBI)
Type: Clinical Investigator Award (CIA) (K08)
Project #: 5K08HL002686-03
Application #: 2210371
Study Section: Special Emphasis Panel (SRC (MN))

Project Start: 1991-08-01
Project End: 1994-09-30
Budget Start: 1994-01-01
Budget End: 1994-09-30
Support Year: 3
Fiscal Year: 1994
Total Cost
Indirect Cost

Institution

Name: Brigham and Women's Hospital
Department
Type
DUNS #: 071723621

City: Boston
State: MA
Country: United States
Zip Code: 02115

Related projects


NIH 1996 K08 HL	In Vitro and IN Vivo Studies of the Human IL-4 Receptor Seldin, David C. / Boston Medical Center
NIH 1995 K08 HL	In Vitro and IN Vivo Studies of the Human IL-4 Receptor Seldin, David C. / Boston Medical Center
NIH 1994 K08 HL	In Vitro and IN Vivo Studies of the Human IL-4 Receptor Seldin, David C. / Brigham and Women's Hospital
NIH 1994 K08 HL	In Vitro and IN Vivo Studies of the Human IL-4 Receptor Seldin, David C. / Boston Medical Center
NIH 1993 K08 HL	In Vitro and IN Vivo Studies of the Human IL-4 Receptor Seldin, David C. / Brigham and Women's Hospital
NIH 1991 K08 HL	In Vitro and IN Vivo Studies of the Human IL-4 Receptor Seldin, David C. / Brigham and Women's Hospital

Publications

Kelliher, M A; Seldin, D C; Leder, P (1996) Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J 15:5160-6

Seldin, D C; Leder, P (1994) Mutational analysis of a critical signaling domain of the human interleukin 4 receptor. Proc Natl Acad Sci U S A 91:2140-4

Skoda, R C; Seldin, D C; Chiang, M K et al. (1993) Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J 12:2645-53

Comments

Be the first to comment on David Seldin's grant